Marek Bartkuhn Selected Research

Sepsis (Septicemia)

1/2018	Impact of human sepsis on CCCTC-binding factor associated monocyte transcriptional response of Major Histocompatibility Complex II components.
1/2015	Sepsis induces specific changes in histone modification patterns in human monocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marek Bartkuhn Research Topics

Disease

5	Neoplasms (Cancer) 12/2019 - 01/2014
3	Inflammation (Inflammations) 01/2020 - 01/2014
2	Infections 01/2021 - 06/2019
2	Sepsis (Septicemia) 01/2018 - 01/2015
1	Hypoxia (Hypoxemia) 07/2022
1	Cystitis 01/2021
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 06/2019
1	Lung Neoplasms (Lung Cancer) 01/2017
1	Carcinogenesis 06/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 06/2014
1	Borderline Personality Disorder (Personality Disorders, Borderline) 01/2013
1	Infertility (Sterility) 09/2010

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 01/2021 - 01/2014
3	ChromatinIBA 01/2020 - 09/2010
2	EnzymesIBA 07/2022 - 06/2019
2	DNA (Deoxyribonucleic Acid)IBA 12/2019 - 06/2019
1	Hydroxyl RadicalIBA 07/2022
1	oxalylglycineIBA 07/2022
1	Mixed Function Oxygenases (Monooxygenases)IBA 07/2022
1	Acetates (Acetic Acid Esters)FDA Link 01/2021
1	Tumor Biomarkers (Tumor Markers)IBA 12/2019
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 06/2019
1	Intergenic DNA (Junk DNA)IBA 01/2018
1	HLA-DR Antigens (HLA-DR)IBA 01/2018
1	CCCTC-Binding FactorIBA 01/2018
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2017
1	Lysine (L-Lysine)FDA Link 01/2015
1	Histones (Histone)IBA 01/2015
1	NucleoproteinsIBA 06/2014
1	Transcription Factors (Transcription Factor)IBA 06/2014
1	CyclinsIBA 06/2014
1	ChemokinesIBA 01/2014
1	Biological ProductsIBA 01/2014
1	Messenger RNA (mRNA)IBA 09/2010

Therapy/Procedure

2	Therapeutics 12/2019 - 01/2013